Live tape
Top 8, mentions 7d17,472MSFT3,299 mentions▲ +0.08GOOGL2,673 mentions▲ +0.05AAPL2,273 mentions▲ +0.07META2,223 mentions▲ +0.04SPCX1,992 mentions▲ +0.06SNDK1,838 mentions▲ +0.06NVDA1,749 mentions▲ +0.07QQQ1,425 mentions▲ +0.04

Equity · Healthcare

CYTK

Cytokinetics, Incorporated · NasdaqGS

$81.00 −1.22% 1D Finazon · prior-day close · Jul 24, 2026
Price · Chart Chart by TradingView
Track this symbol on TradingView

The chart above plots the price of CYTK over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 60 sessions over that window: $63.00 on 1 May 2026 through $81.00 on 24 July 2026. Finazon · prior-day close.

Market cap $10.1B
52-week range $33.20 – $87.31
Avg volume 477.5K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

CYTK insider trades

SEC Form 4 · last 90 days · newest reported trade 27 Jul 2026
Open-market buys 0
Open-market sells 24
Net sold $17.30M
Non-trade filings 32
Date Insider Type Shares Value
27 Jul 2026 Blum Robert I President & CEO Sell 7,500 $607K
21 Jul 2026 Malik Fady Ibraham EVP Research & Development Sell 3,500 $282K
13 Jul 2026 Blum Robert I President & CEO Sell 7,500 $615K

Showing the 12 most recent of 56 filings in this window. The figures above count all of them.

Compensation mechanics (9 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
27 Jul 2026 Blum Robert I President & CEO Option exercise 7,500 $80K
21 Jul 2026 Malik Fady Ibraham EVP Research & Development Option exercise 3,500 $27K
15 Jul 2026 Daly James M Director Award 151 $12K
15 Jul 2026 Harrington Robert Arthur Director Award 151 $12K
15 Jul 2026 HENDERSON JOHN T Director Award 272 $22K
15 Jul 2026 Kaye Edward M. MD Director Award 151 $12K
15 Jul 2026 WIERENGA WENDELL Director Award 75 $6K
15 Jul 2026 Wysenski Nancy Director Award 75 $6K
13 Jul 2026 Blum Robert I President & CEO Option exercise 7,490 $79K

CYTK reported financials

SEC EDGAR XBRL

CYTK reported revenue of $88.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$785.0M.

Figure Reported Period
Revenue $88.0M 31 Dec 2025 fiscal year
Net income −$785.0M 31 Dec 2025 fiscal year
Diluted EPS −$6.54 31 Dec 2025 fiscal year
Total assets $1.3B 31 Mar 2026 at period end
Total equity −$826.6M 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

CYTK earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-1.67 —
31 Dec 2025 FY 2025 $-6.54 —
30 Sep 2025 Q3 2025 $-2.55 —
30 Jun 2025 Q2 2025 $-1.12 —

Reported figures & scheduled dates · SEC EDGAR filings

CYTK institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a CYTK position for the quarter ended 31 Mar 2026 — a combined $355.9M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Citadel Advisors Held (±25%) −5.4% shares 1,099,858 $72.5M
Balyasny Asset Management New position 992,545 $65.4M
Fisher Asset Management Held (±25%) −6.6% shares 768,264 $50.6M
D. E. Shaw & Co. Added +492.7% shares 706,631 $46.6M
Marshall Wace Added +94.8% shares 656,608 $43.3M
Point72 Asset Management New position 626,102 $41.3M
Two Sigma Investments Held (±25%) +4.0% shares 285,008 $18.8M
AQR Capital Management Trimmed −33.9% shares 156,544 $10.3M
Millennium Management Trimmed −56.6% shares 97,959 $6.5M
Man Group Held (±25%) −9.7% shares 10,463 $690K

Source: SEC EDGAR 13F filings

CYTK fails-to-deliver

SEC CNS data

On 30 Jun 2026, 19,989 shares of CYTK failed to deliver (about $1.7M) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
30 Jun 2026 19,989 $1.7M 0.016%
29 Jun 2026 31,203 $2.6M 0.025%
24 Jun 2026 2,276 $182K 0.002%
22 Jun 2026 17,045 $1.3M 0.014%
17 Jun 2026 2,128 $160K 0.002%
15 Jun 2026 1,750 $123K 0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in CYTK

STOCK Act disclosures

The most recent congressional trade disclosed in CYTK is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 30 Jun 2026.

Date Member Type Amount
30 Jun 2026 filed 02 Jul 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures